Protagenic Therapeutics Inc. (PTIX) Live Share Price, Invest From India

Protagenic Therapeutics Inc. Stock Performance

as on July 11, 2026 at 6:45 am IST

Day's Low
$0.14
Day's Price Range
$0.26
$0.26
46.15%
Downside
52 Week's Low
52 Week's High
$0.14
52-Week Price Range
$6.20
$0.26
46.15%
Downside
2284.62%
Upside

Protagenic Therapeutics Inc. share price movements today

Previous Close: $0.22
Open: $0.14
Volume: 329.1K
Day's Low - High: $0.14 - $0.26
52 Week Low - High: $0.14 - $6.20

Protagenic Therapeutics Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Protagenic Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Protagenic Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$470.7K

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-5.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-512.79%

Protagenic Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protagenic Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Protagenic Therapeutics Inc.	BUY	$470.7K	NA	NA	0.00%	NA
Insmed Inc.	BUY	$25.1B	305.51%	NA	-144.44%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.9B	70.11%	75.25	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$123.2B	144.74%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$69.7B	15.17%	16.24	29.65%	0.54%

Analyst Recommendation on Protagenic Therapeutics Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Protagenic Therapeutics Inc.. Average target price of $4

Protagenic Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Protagenic Therapeutics Inc..

What analysts predicted

93.5%UPSIDE

Target Price

Current Price

$0.26

Analyzed by

7 Analysts

Target

$4.00

Protagenic Therapeutics Inc. target price $4, a slight upside of 93.5% compared to current price of $0.26. According to 7 analysts rating.

Protagenic Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	0	-	0	0	-	-	-	-
Gross Profit	0	-	0	0	0	0	0	0	0	-
Operating Income	-1	-1	-1	-1	0	-1	-1	-2	-1	0
EBITDA	-1	-	-1	-1	0	-1	-1	-4	0	0
Interest Expense	0	0	0	-	-	-	-	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	-1	0	-1	-1	-5	0	2
Income Tax Expense	0	-	0	0	0	0	-	-	-	-
Net Income	-1	-1	-1	-1	0	-1	-1	-5	0	2
Net Profit Margin	0.00%	0.00%	-53875.00%	0.00%	-2549.42%	6180.65%	0.00%	0.00%	0.00%	0.00%

Protagenic Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-	0	0	0
Operating Income	-2	-2	-2	-2	-2	-4	-3	-4	-5
EBITDA	-2	-2	-2	-2	-2	-4	-3	-4	-5
Interest Expense	0	0	0	0	0	0	0	0	-
Depreciation	-	0	0	0	0	0	0	0	0
Income Before Tax	-2	-2	-2	-1	-2	-4	-3	-5	-5
Income Tax Expense	0	0	0	0	0	0	0	0	-
Net Income	-2	-2	-2	-1	-2	-4	-3	-5	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Protagenic Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-1	-1	-1	0	-1	-1	-5	-4	2
Operating Cash Flow	-1	-1	-1	0	0	-1	-1	-1	0
Investing Cash Flow	-	1	1	-	-	-	0	0	0
Financing Cash Flow	-	0	0	0	1	0	4	0	0
Change in Cash	1	0	0	0	0	0	4	1	0

Protagenic Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-2	-1	-2	-4	-3	-5	-5	-5
Operating Cash Flow	-1	-1	0	-1	-2	-1	-3	-4	-4
Investing Cash Flow	-1	1	0	-9	-9	1	4	2	0
Financing Cash Flow	0	0	0	1	12	-	-	1	4
Change in Cash	-2	0	0	0	0	0	1	0	4

Global Institutional Holdings in Protagenic Therapeutics Inc.

Funds	Holdings
Geode Capital Management, LLC	0%
Citigroup Inc	0%
Morgan Stanley - Brokerage Accounts	0%
Susquehanna International Group, LLP	0%
Vanguard Group Inc	0%

See all

Insights on Protagenic Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 165.0% return, outperforming this stock by 257.9%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 847.0% return, outperforming this stock by 944.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PTIX stock has moved down by -56.2%

About Protagenic Therapeutics Inc.

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Organisation	Protagenic Therapeutics Inc.
Headquarters	701 Anacapa Street, Santa Barbara, CA, United States, 93101
Industry	Biotechnology
CEO	Dr. Garo H. Armen Ph.D.
E-voting on shares	Click here to vote

Key Management of Protagenic Therapeutics Inc.

Name	Title
Dr. Garo H. Armen Ph.D.	Executive Chairman
Mr. William Nichols Jr.	President
Dr. Robert Benjamin Stein M.D., Ph.D.	Chief Medical Officer

FAQs

What is Protagenic Therapeutics Inc. share price today?

Protagenic Therapeutics Inc. share price today is $0.26 as on July 11, 2026 at 1:15 am IST. Protagenic Therapeutics Inc. share today touched a day high of $0.26 and a low of $0.14.

What is the 52 week high and 52 week low for Protagenic Therapeutics Inc. share?

Protagenic Therapeutics Inc. share touched a 52 week high of $6.20 on August 21, 2025 and a 52 week low of $0.14 on July 10, 2026. Protagenic Therapeutics Inc. stock price today i.e. July 11, 2026 at 1:15 am IST is trending at $0.26,which is 95.81% down from its 52 week high and 85.71% up from its 52 week low.

What is Protagenic Therapeutics Inc.'s market capitalisation today?

Protagenic Therapeutics Inc. market capitalisation is $0.00T as on July 11, 2026 at 1:15 am IST.

How to invest in Protagenic Therapeutics Inc. Stock (PTIX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Protagenic Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protagenic Therapeutics Inc. Shares that will get you 5.7692 shares as per Protagenic Therapeutics Inc. share price of $0.26 per share as on July 11, 2026 at 1:15 am IST.

What is the minimum amount required to buy Protagenic Therapeutics Inc. Stock (PTIX) from India?

Indian investors can start investing in Protagenic Therapeutics Inc. (PTIX) shares with as little as ₹95.615 or $1 (as of July 13, 2026 at 10:54 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.15 in Protagenic Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 13, 2026 at 10:54 pm IST). Based on Protagenic Therapeutics Inc. share’s latest price of $0.26 as on July 11, 2026 at 1:15 am IST, you will get 38.4615 shares of Protagenic Therapeutics Inc.. Learn more about fractional shares .